Short answer
LivaNova PLC (LIVN) filed its fiscal 2025 10-K annual report with the SEC on Feb 25, 2026. It reported revenue of $1.4B (+10.7% year over year) and net income of −$242M.
- Top risk flagged: Regulatory risk from 3T Heater-Cooler device litigation provision reducing cash outflows by $71.3M in 2025
FY2025 key financial metrics · XBRL
- Revenue
- $1.4B
- +10.7% YoY
- Net income
- −$242M
- −483.5% YoY
- Operating margin
- 14.4%
- +4.1 pp YoY
- Gross margin
- 67.7%
- −1.8 pp YoY
- EPS (diluted)
- −$4.45
- −483.6% YoY
- ROE
- -20.2%
- −25.0 pp YoY
- Operating cash flow
- $254M
- +39.0% YoY
Source: XBRL data from the LivaNova PLC (LIVN) FY2025 10-K on SEC EDGAR. USD.
LivaNova PLC FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model: Medical technology company with Cardiopulmonary and Neuromodulation segments driving revenue
- New product emphasis: aura6000 System for treating Obstructive Sleep Apnea, increasing Neuromodulation R&D expense by $11.2M
- Strategic shift: Reduced litigation provision for 3T Heater-Cooler device by $15.3M, improving Cardiopulmonary segment income
- Quantitative metric: Net revenue up 10.7% to $1.39B; Cardiopulmonary revenue up 14.9%, Neuromodulation up 7.0% YoY
- Noteworthy fact: $366M SNIA environmental liability expense recorded due to 2025 Italian Supreme Court ruling on joint liability
Management Discussion & Analysis
- Revenue and YoY change not disclosed explicitly in provided text
- No profitability or margin % figures available in text
- Cash flow, buybacks, dividends, capex details not included
- Risks from FX volatility, inflation, geopolitical instability, supply chain challenges highlighted as key emerging risks
Risk Factors
- Regulatory risk from 3T Heater-Cooler device litigation provision reducing cash outflows by $71.3M in 2025
- Geopolitical risk from exposure to hospital and healthcare sectors across multiple countries affecting trade receivables concentration
- Operational risk from increased investing activities $33.9M in plant, property, and software for manufacturing capacity expansion
- Competitive risk from sale of Ceribell, Inc. investment for $6.5M indicating strategic shift or response to market
- Financial risk from debt reduction $280.9M in 2025 lowered debt from $627.6M to $376.7M, decreasing leverage ratio from 47.5% to 31.4% equity
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.